Teva Pharmaceutical Industries Limited (TLV: TEVA)

Market Cap	87.95B
Revenue (ttm)	62.35B
Net Income (ttm)	-3.56B
Shares Out	n/a
EPS (ttm)	-3.18
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	670,390
Average Volume	944,075
Open	7,969.00
Previous Close	7,969.00
Day's Range	7,798.00 - 7,979.00
52-Week Range	4,023.00 - 8,431.00
Beta	0.87
RSI	59.85
Earnings Date	Jan 29, 2025

About TLV: TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 36,472
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: TEVA

Financial Performance

In 2023, TEVA's revenue was $15.85 billion, an increase of 6.17% compared to the previous year's $14.93 billion. Losses were -$559.00 million, -77.15% less than in 2022.

Financial numbers in USD